Schedule 2 Other dangerous drugs
COLUMN 1 Substance or thing |
COLUMN 2 |
COLUMN 3 |
Acetorphine |
2.00 g |
100.00 g |
Acetyl-a-methylfentanyl |
0.005 g |
0.25 g |
Acetyldihydrocodeine, except when compounded with one or more other medicaments: |
|
|
(a) in divided preparations containing not more than 100 mg of acetyldihyd-rocodeine per dosage unit; or |
||
(b) in undivided preparations with a concentration of not more than 2.5% of acetyldihydrocodeine | | |
Acetylmethadol |
2.00 g |
100.00 g |
Acetylmorphines |
2.00 g |
100.00 g |
Adamantoylindoles |
50.0 g |
500.00 g |
Adamantylamidoindazoles |
50.0 g |
500.00 g |
Adamantylamidoindoles |
50.0 g |
500.00 g |
Alfentanil |
0.005 g |
0.25 g |
Alkoxyamphetamines and substituted alkoxyamphetamines except if separately specified in this Schedule |
|
|
Alkoxyphenethylamines and substituted alkoxyphenylethylamines except if separately specified in this Schedule |
|
|
Alkythioamphetamines |
0.50 g |
25.00 g |
Allylprodine |
2.00 g |
100.00 g |
Alphacetylmethadol |
10.00 g |
500.00 g |
Alphameprodine |
0.20 g |
10.00 g |
Alphamethadol |
0.20 g |
10.00 g |
Alpha-methyltryptamine |
2.00 g |
100.00 g |
Alphaprodine |
25.00 g |
1.25 kg |
2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM) |
|
|
N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA) |
50.00 g |
500.00 g |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5-FLUORO-ADB-PINACA) |
50.00 g |
50.00 g |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) |
50.00 g |
500.00 g |
(S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- (5-fluoropentyl)-1H-indazole-3-carboxamide (5-FLUORO-AB-PINACA) |
50.00 g |
500.00 g |
(S)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) |
50.00 g |
500.00 g |
N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide (AB-FUBINACA) |
50.00 g |
500.00 g |
5-(2-Aminopropyl)Benzofuran (5-APB) |
2.00 g |
100.00 g |
6-(2-Aminopropyl)Benzofuran (6-APB) |
2.00 g |
100.00 g |
5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-ADPB) |
2.00 g |
100.00 g |
6-(2-Aminopropyl)-2,3-dihydrobenzofuran (6-ADPB) |
2.00 g |
100.00 g |
Amylobarbitone |
20.00 g |
1.00 kg |
Anileridine |
25.00 g |
1.25 kg |
| | |
Benzethidine |
10.00 g |
500.00 g |
Benzoylindoles |
50.0 g |
500.00 g |
Benzylmorphine |
5.00 g |
250.00 g |
Benzylpiperazine |
2.00 g |
100.00 g |
Betacetylmethadol |
5.00 g |
250.00 g |
Betameprodine |
5.00 g |
250.00 g |
Betamethadol |
5.00 g |
250.00 g |
Betaprodine |
5.00 g |
250.00 g |
Bezitramide |
5.00 g |
250.00 g |
Bromo-dimethoxyamphetamine |
0.05 g |
2.50 g |
Bromo-dimethoxyphenethylamine |
0.50 g |
25.00 g |
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) |
|
|
Bromo-methoxyamphetamine |
0.50 g |
25.00 g |
Bufotenine |
2.00 g |
100.00 g |
Butobarbitone |
20.00 g |
1.00 kg |
Butorphanol |
2.00 g |
100.00 g |
| | |
Cannabis oil |
1.00 g |
25.00 g |
Cannabis plant |
not less than 5 nor more than 19 plants |
not less than 20 plants |
Cannabis plant material (being any part of the Cannabis plant, including the flowering or fruiting tops, leaves, stalks and seeds) other than permissible Cannabis seeds |
|
|
Cannabis resin |
10.00 g |
100.00 g |
Cannabis seed, other than permissible Cannabis seeds |
10.00 g |
100.00 g |
Cathinone |
2.00 g |
100.00 g |
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) |
|
|
Clonitazene |
5.00 g |
250.00 g |
Coca Leaf |
250.00 g |
5.00 kg |
Codeine except when compounded with one or more other medicaments: (a) in divided preparations containing 30 mg or less of codeine per dosage unit; or (b) in undivided preparations containing 1% or less of codeine |
|
|
Codeine-N-oxide |
10.00 g |
500.00 g |
Codoxime |
10.00 g |
500.00 g |
Concentrate of Poppy Straw (the material arising when poppy straw has entered into a process for concentration of its alkaloids) |
|
|
CUMYL-PeGACLONE (SGT-151) |
50.00 g |
500.00 g |
4-Cyano-2-dimethylamino-4, |
|
|
4-Cyano-1-methyl-4-phenylpiperidine (Pethidine intermediate A) |
|
|
Cyclobarbitone |
20.00 g |
1.00 kg |
1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (RCS-8) |
|
|
Cyclohexylphenols |
50.0 g |
500.00 g |
Cyclopropanoylindoles |
50.0 g |
500.00 g |
| | |
Desomorphine |
2.00 g |
100.00 g |
Dextromoramide |
2.00 g |
100.00 g |
Dextropropoxyphene, except when: (a) in divided preparations containing 135 mg or less of dextropropoxyphene per dosage unit; or (b) in liquid preparations containing 2.5% or less of dextropropoxyphene |
27.00 g |
1.35 kg |
Diampromide |
5.00 g |
250.00 g |
3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl] benzamide (AH-7921) |
2.00 g |
100.00 g |
Diethylthiambutene |
5.00 g |
250.00 g |
N,N-Diethyltryptamine (DET) |
2.00 g |
100.00 g |
Difenoxin, except in preparations containing, per dosage unit. 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin |
|
|
Dihydrocodeine, except when compounded with one or more other medicaments: (a) in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or (b) in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine |
|
|
Dihydromorphine |
10.00 g |
500.00 g |
Dimenoxadol |
10.00 g |
500.00 g |
Dimepheptanol |
10.00 g |
500.00 g |
Dimethoxyamphetamine |
0.50 g |
25.00 g |
Dimethoxyethoxyamphetamine |
0.50 g |
25.00 g |
Dimethoxyethylamphetamine |
0.50 g |
25.00 g |
Dimethoxymethamphetamine |
0.50 g |
25.00 g |
Dimethoxymethylenedioxyamphetamine |
0.50 g |
25.00 g |
Dimethoxyphenethylamine |
0.50 g |
25.00 g |
2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25H–NBOMe) |
0.50 g |
25.00 g |
Dimethyamylamine (DMAA) |
2.00 g |
100.00 g |
3-(2-Dimethylaminoethyl)-4-hydroxyindole (Psilocine, Psilotsin) |
|
|
3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo (b,d)pyran (DMHP) |
|
|
Dimethylthiambutene |
20.00 g |
1.00 kg |
N,N,-Dimethyltryptamine (DMT) |
2.00 g |
100.00 g |
Dioxaphetyl Butyrate |
2.00 g |
100.00 g |
Diphenoxylate, except in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate |
|
|
Dipipanone |
10.00 g |
500.00 g |
Drotebanol |
2.00 g |
100.00 g |
| | |
Ecgonine |
10.00 g |
1.00 kg |
Ethylamphetamine |
2.00 g |
100.00 g |
4,5-Ethylenedioxy-3-methoxyamphetamine |
|
|
Ethylmethylthiambutene |
10.00 g |
500.00 g |
Ethylmorphine, except when compounded with one or more other medicaments: (a) in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or (b) in undivided preparations with a concentration of not more than 2.5% of ethylmorphine |
|
|
Eticyclidine (PCE) |
2.00 g |
100.00 g |
Etonitazene |
5.00 g |
250.00 g |
Etorphine |
5.00 g |
250.00 g |
Etoxeridine |
5.00 g |
250.00 g |
| | |
Fenetylline |
2.00 g |
100.00 g |
Fentanyl |
0.005 g |
0.25 g |
5-fluoro-AB-P7AICA |
50.00 g |
500.00 g |
5-fluoro CUMYL-P7AICA |
50.00 g |
500.00 g |
Fluorofentanyl |
0.005 g |
0.25 g |
Fluoromethcathinone |
2.00 g |
100.00 g |
(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone (XLR11) |
|
|
1-(5-fluoropentyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide (5-FLUORO-CUMYL-PINACA) |
|
|
1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694) |
|
|
1-(5-Fluoropentyl)-3-(1-naphthoyl)indole (AM-2201) |
|
|
Furethidine |
1.00 g |
50.00 g |
| | |
Harmaline |
2.00 g |
100.00 g |
Harmine |
2.00 g |
100.00 g |
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo(b,d)pyran (Parahexyl) |
|
|
1-Hexyl-3-(1-naphthoyl)indole (JWH-019) |
|
|
Hydrocodone |
2.00 g |
100.00 g |
Hydromorphinol |
2.00 g |
100.00 g |
Hydromorphone |
2.00 g |
100.00 g |
2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol (Cannabicyclohexanol or CP 47,497 C8 homologue) |
|
|
2-[(1R,3S)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol (CP 47,497) |
|
|
Hydroxyfentanyl |
0.005 g |
0.25 g |
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6A,7,10,10A-tetrahydrobenzo[c]chromen-1-ol
|
|
|
Hydroxymethylfentanyl |
0.005 g |
0.25 g |
Hydroxypethidine |
5.00 g |
250.00 g |
4-Hydroxybutanoic acid |
2.00 g |
100.00 g |
| | |
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) |
|
|
Isomethadone |
2.00 g |
100.00 g |
| | |
Ketobemidone |
2.00 g |
100.00 g |
Khat leaf |
250.00 g |
5.00 kg |
| | |
Levomethorphan |
2.00 g |
100.00 g |
Levomoramide |
2.00 g |
100.00 g |
Levophenacylmorphan |
2.00 g |
100.00 g |
Levorphanol |
1.00 g |
50.00 g |
| | |
Mecloqualone |
60.00 g |
3.00 kg |
Metazocine |
7.00 g |
350.00 g |
Methadone |
2.00 g |
100.00 g |
Methanandamide |
50.00 g |
500.00 g |
Methaqualone |
50.00 g |
2.50 kg |
Methcathinone |
2.00 g |
100.00 g |
5-methoxy-N,N-diallyltryptamine |
2.00 g |
100.00 g |
5-methoxy- α -methyltryptamine (5-MeO-AMT) |
2.00 g |
100.00 g |
Methoxyethylenedioxyphenylethylamine |
0.50 g |
25.00 g |
Methoxymethylenedioxyphenethylamine |
0.50 g |
25.00 g |
4-Methoxyphenyl(1butyl-1h-indol-3-yl)-methanone (RCS-4 (C4)) |
|
|
2-(4-Methoxyphenyl)-1-(1-pentyl-1h-indol-3-yl)-ethanone (JWH-201) |
|
|
2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-250) |
|
|
2-(3-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone (JWH-302) |
|
|
Methoxyphenylethylamine |
0.50 g |
25.00 g |
α-methylamino-valerophenone (pentedrone) |
2.00 g |
100.00 g |
Methylenedioxymethcathinone (methylone) |
2.00 g |
100.00 g |
Methylenedioxypyrovalerone (MDPV) |
2.00 g |
100.00 g |
2-Methyl-3-morpholino-1,1-diphenylpropane Carboxylic Acid (Moramide intermediate) |
|
|
1-Methyl-4-phenylpiperidine-4-carboxylic acid (Pethidine intermediate C) |
|
|
1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP) |
|
|
Methyldesorphine |
2.00 g |
100.00 g |
Methyldihydromorphine |
2.00 g |
100.00 g |
Methylfentanyl |
0.005 g |
0.25 g |
Methylmethcathinone |
2.00 g |
100.00 g |
Methylphenidate |
2.00 g |
100.00 g |
Methylthiofentanyl |
0.005 g |
0.25 g |
Metopon |
2.00 g |
100.00 g |
Morpheridine |
2.00 g |
100.00 g |
Morphine |
2.00 g |
100.00 g |
Morphine Methobromide |
2.00 g |
100.00 g |
Morphine-N-oxide |
2.00 g |
100.00 g |
(1-(2-Morpholin-4-ylethyl)indol-3-yl)-naphthalen-1-ylmethanone (JWH-200) |
|
|
Muscimol |
2.00 g |
100.00 g |
Myrophine |
20.00 g |
1.00 kg |
| | |
N-adamantyl-1-fluoropentylindole-3-Carboxamide (STS-135) |
|
|
N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (AKB48) |
|
|
1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl) indole (AM-1248) |
|
|
Nabilone |
0.40 g |
20.00 g |
Naphthalen-1-yl-(1-butylindol-3-yl)methanone |
|
|
Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (NM2201) |
|
|
N-1-naphthalenyl-1-pentyl-1H-indole-3-carboxamide (NNEI) |
50.00 g |
500.00 g |
Naphthoylindoles |
50.0 g |
500.00 g |
Naphthoylpyrroles |
50.0 g |
500.00 g |
Naphthylmethylindenes |
50.0 g |
500.00 g |
Naphthylmethylindoles |
50.0 g |
500.00 g |
Nicocodine, except when compounded with one or more other medicaments: (a) in divided preparations containing not more than 100 mg of nicocodine per dosage unit; or (b) in undivided preparations with a concentration of not more than 2.5% of nicocodine |
|
|
Nicodicodine, except when compounded with one or more other medicaments: (a) in divided preparations containing not more than 100 mg of nicodicodine per dosage unit; or (b) in undivided preparations with a concentration of not more than 2.5% of nicodicodine |
|
|
Nicomorphine |
2.00 g |
100.00 g |
Noracylmethadol |
2.00 g |
100.00 g |
Norcodeine, except when compounded with one or more other medicaments: (a) in divided preparations containing not more than 100 mg of norcodeine per dosage unit; or (b) in undivided preparations with a concentration of not more than 2.5% of norcodeine |
|
|
Norlevorphanol |
2.00 g |
100.00 g |
Normethadone |
5.00 g |
250.00 g |
Normorphine |
20.00 g |
1.00 kg |
Norpipanone |
10.00 g |
500.00 g |
| | |
Opium in any form, except the alkaloids noscapine and papaverine |
|
|
Oxycodone |
5.00 g |
250.00 g |
Oxymorphone |
2.00 g |
100.00 g |
| | |
Parahexyl |
– |
– |
Pentazocine |
20.00 g |
1.00 kg |
Pentobarbitone |
20.00 g |
1.00 kg |
1-Pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
|
|
1-Pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
|
|
1-Pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210) |
|
|
1-Pentyl-1h-indol-3-yl-(1-naphthoyl)menthane |
|
|
1-Pentyl-3-[(4-methoxy)-benzoyl]indole (RCS-4) |
|
|
1-Pentyl-3-(4-methoxynaphthoyl)indole (JWH-081) |
|
|
1-Pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
|
|
1-Pentyl-3-(1-naphthoyl)indole (JWH-018) |
|
|
(1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (UR144) |
|
|
Pethidine |
10.00 g |
500.00 g |
Phenadoxone |
10.00 g |
500.00 g |
Phenampromide |
10.00 g |
500.00 g |
Phenazocine |
1.00 g |
50.00 g |
Phendimetrazine |
5.00 g |
250.00 g |
Phenmetrazine |
5.00 g |
250.00 g |
Phenomorphan |
5.00 g |
250.00 g |
Phenoperidine |
1.00 g |
50.00 g |
Phenylacetylindoles |
50.0 g |
500.00 g |
1-Phenylethyl-4-phenyl-4-acetoxypiperidine (PEPAP) |
|
|
4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester (Pethidine intermediate B) |
|
|
Pholcodine, except when compounded with one or more other medicaments: (a) in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or (b) in undivided preparations with a concentration of not more than 2.5% of pholcodine |
|
|
Piminodine |
10.00 g |
500.00 g |
Piritramide |
1.00 g |
50.00 g |
Pravadoline (WIN 48098) |
50.00 g |
500.00 g |
Proheptazine |
1.00 g |
50.00 g |
Prohibited plant, other than elsewhere described in this Schedule |
not less than 5 nor more than 19 plants |
not less than 20 plants |
Properidine |
25.00 g |
1.25 kg |
Propiram |
10.00 g |
500.00 g |
1-Propyl-2-methyl-3-(1-naphthoyl)indole (JWH-015) |
|
|
Psilocybin and its derivatives |
0.10 g |
5.00 g |
Pyrrolidinobutiophenone |
2.00 g |
100.00 g |
Pyrrolidinopentiophenone |
2.00 g |
100.00 g |
Pyrrolidinopropiophenone |
2.00 g |
100.00 g |
| | |
Quinalbarbitone |
20.00 g |
1.00 kg |
| | |
Racemethorphan |
2.00 g |
100.00 g |
Racemoramide |
2.00 g |
100.00 g |
Racemorphan |
2.00 g |
100.00 g |
Rolicyclidine (PHP, PCPY) |
2.00 g |
100.00 g |
| | |
Salvia Divinorum, including extracts and other substances structurally derived from Salvia Divinorum |
|
|
Secbutobarbitone |
20.00 g |
1.00 kg |
Sufentanil |
0.005 g |
0.25 g |
| | |
Tenocyclidine (TCP) |
2.00 g |
100.00 g |
Tetrahydrocannabinols and their alkyl homologues except: | | |
(a) if separately specified in this Schedule; or | | |
(b) in hemp seed oil: | | |
(i) containing more than 10 and not more than 50 mg/kg or less of tetrahydrocannabinols, when labelled "Not for internal use" or "Not to be taken"; or | | |
(ii) containing not more than 10 mg/kg of tetrahydrocannabinols; or | | |
(c) in products for purposes other than internal human use containing 50 mg/kg or less of tetrahydrocannabinols; or | | |
(d) in products made from permissible Cannabis seeds and intended for human consumption as a food that contain not more than 5 mg/kg of tetrahydrocannabinols; or | | |
(e) in products made from permissible Cannabis seeds and intended for human consumption as a beverage that contain not more than 2 mg/kg of tetrahydrocannabinols. | | |
Tetramethoxyamphetamine |
0.50 g |
25.00 g |
Thebacon |
2.00 g |
100.00 g |
Thebaine |
2.00 g |
100.00 g |
Thiofentanyl |
0.005 g |
0.25 g |
Tilidine |
20.00 g |
1.00 kg |
Trifluoromethylphenylpiperazine and other piperazine derivatives |
|
|
Trimeperidine |
10.00 g |
500.00 g |
Trimethoxyamphetamine |
0.50 g |
25.00 g |
Trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine, except: (a) methoxyphenamine; or (b) where separately specified in this Schedule |
|
|
Trimethoxyphenyl-aminobutane |
0.50 g |
25.00 g |
| | |
Anabolic Steroids: |
|
|
Testosterone propionate except anabolic steroids in products packaged for ovulation control or in quantities which can lawfully be prescribed as a Schedule 4 substance under the Medicines, Poisons and Therapeutic Goods Act 2012 |
12.00 g |
600.00 g |